Perrigo launches generic version of Neptazane tablets Perrigo has launched methazolamide tablets, the generic equivalent to Neptazane tablets. This product is a component of the contingent rights Perrigo received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals last June. Methazolamide tablets are indicated for the treatment of several ocular conditions. Estimated annual sales are approximately $12M.
News For PRGO From The Last 14 Days
Check below for free stories on PRGO the last two weeks.